Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report (Articolo in rivista)

Type
Label
  • Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report (Articolo in rivista) (literal)
Anno
  • 2009-01-01T00:00:00+01:00 (literal)
Alternative label
  • Lambiase A.a);Coassin M.a); Tirassa P. b); Mantelli F. a); Aloe L. b) (2009)
    Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report
    in Annali dell'Istituto superiore di sanità
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Lambiase A.a);Coassin M.a); Tirassa P. b); Mantelli F. a); Aloe L. b) (literal)
Pagina inizio
  • 439 (literal)
Pagina fine
  • 442 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 45 (literal)
Rivista
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • (a) Dipartimento di Oftalmologia, Università Campus Biomedico, Rome, Italy (b) Istituto di Neurobiologia e Medicina Molecolare, CNR, Rome, Italy (literal)
Titolo
  • Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report (literal)
Abstract
  • Age-related macular degeneration (ARMD) is a severe disease affecting visual function in the elderly. Currently available surgical and medical options do not guarantee a significant impact on the outcome of the disease. We describe the effects of nerve growth factor eye drop treatment in a 94 years old female with ARMD, whose visual acuity was progressively worsening in spite of previous surgical and medical treatments. NGF eye drops improved visual acuity and electrofunctional parameters as early as 3 months after initiation of treatment. These results are in line with previous reports on a neuroprotective effect of NGF on retinal cells and on NGF eye drops bioavailability in the retina and optic nerve. No side effects were observed after five years of follow-up, suggesting that topical NGF treatment may be a safe and effective therapy for ARMD. (literal)
Prodotto di
Autore CNR
Insieme di parole chiave

Incoming links:


Prodotto
Autore CNR di
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
Insieme di parole chiave di
data.CNR.it